Delivery Order SPE2DB20D3101-SPE2DB23FRAX1
Award Date
1/23/23
Potential Completion Date
1/24/23
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,343.00 Firm Fixed Price Delivery Order is for the supply of 4565826728 units of Insulin Lispro 100 Unit/mL Pen 3mL, with a completion date of September 17, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.84 Firm Fixed Price Delivery Order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes management medication. The contract has an ultimate completion date of August 22, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,275.48, is for the delivery of Insulin Lispro 100 Unit/mL Vials (10 mL) to support military healthcare programs. The contract has a firm fixed price and a completion date of July 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,048.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Insulin Lispro 100 Unit/mL Pens, a critical medication for diabetes management. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,647.52 delivery order is for the supply of insulin lispro medication in 3 mL pen format, with a completion date of December 8, 2021. The contract has a firm fixed price pricing type and does not utilize any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug Corp is a...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of insulin lispro 100 unit/ml pen 3ml to support federal healthcare programs. The $1,312.86 firm fixed price delivery order is issued under the Defense Logistics Agency's (DLA) Troop Support Medical Indefinite Delivery Contract, valued at $999,999,999, which runs through November 2026. This contract vehicle enables the DLA to efficiently procure a wide range of pharmaceutical and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,217.42 firm-fixed-price delivery order is for the supply of Humalog 100 Unit/ML KwikPen 3ML insulin pens. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,501.12 firm fixed-price delivery order is for the supply of 4565927956 - INSULIN LISPRO 100 UNIT/ML PEN 3ML, with a final completion date of September 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of INSULIN LISPRO 100 UNIT/ML VL 10ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,003.77 firm fixed-price delivery order contract has an ultimate completion date of December 16, 2024. It is not designated as a set-aside contract. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...